Institutional members access full text with Ovid®

Share this article on:

Rivaroxaban for thromboprophylaxis after hip or knee replacement surgery

Belavic, Jennifer M. PharmD, BCPS, FASCP

doi: 10.1097/01.NPR.0000413489.82497.39
Department: Drug News

Jennifer M. Belavic is a pharmacy manager at the University of Pittsburgh Medical Center–Presbyterian Hospital in Pittsburgh, PA.

The author has disclosed that she has no financial relationships related to this article.

© 2012 Lippincott Williams & Wilkins, Inc.